1. Home
  2. LGND vs EFSC Comparison

LGND vs EFSC Comparison

Compare LGND & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • EFSC
  • Stock Information
  • Founded
  • LGND 1987
  • EFSC 1988
  • Country
  • LGND United States
  • EFSC United States
  • Employees
  • LGND N/A
  • EFSC N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • EFSC Major Banks
  • Sector
  • LGND Health Care
  • EFSC Finance
  • Exchange
  • LGND Nasdaq
  • EFSC Nasdaq
  • Market Cap
  • LGND 2.0B
  • EFSC 2.0B
  • IPO Year
  • LGND 1992
  • EFSC 1999
  • Fundamental
  • Price
  • LGND $122.40
  • EFSC $56.63
  • Analyst Decision
  • LGND Strong Buy
  • EFSC Strong Buy
  • Analyst Count
  • LGND 8
  • EFSC 3
  • Target Price
  • LGND $144.71
  • EFSC $64.33
  • AVG Volume (30 Days)
  • LGND 139.7K
  • EFSC 203.4K
  • Earning Date
  • LGND 08-05-2025
  • EFSC 07-28-2025
  • Dividend Yield
  • LGND N/A
  • EFSC 2.11%
  • EPS Growth
  • LGND N/A
  • EFSC 9.23
  • EPS
  • LGND N/A
  • EFSC 5.09
  • Revenue
  • LGND $181,488,000.00
  • EFSC $619,222,000.00
  • Revenue This Year
  • LGND $18.41
  • EFSC $14.06
  • Revenue Next Year
  • LGND $18.87
  • EFSC $4.85
  • P/E Ratio
  • LGND N/A
  • EFSC $11.16
  • Revenue Growth
  • LGND 53.40
  • EFSC 6.50
  • 52 Week Low
  • LGND $81.74
  • EFSC $38.91
  • 52 Week High
  • LGND $129.90
  • EFSC $63.13
  • Technical
  • Relative Strength Index (RSI)
  • LGND 70.36
  • EFSC 67.94
  • Support Level
  • LGND $111.72
  • EFSC $54.42
  • Resistance Level
  • LGND $115.53
  • EFSC $57.84
  • Average True Range (ATR)
  • LGND 3.46
  • EFSC 1.11
  • MACD
  • LGND 0.18
  • EFSC 0.31
  • Stochastic Oscillator
  • LGND 85.52
  • EFSC 92.85

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About EFSC Enterprise Financial Services Corporation

Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.

Share on Social Networks: